Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Eng

Showing results (311-320 of 385) with videos related to

Pageof 39
Sort By:
Oncogene|August 26, 1998
Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancerM G FitzGerald, D J Marsh, D Wahrer, et al.
Annals of Surgical Oncology|January 14, 2015
Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial NeoplasmsJ H Choe, M J Overman, K F Fournier, et al.
Oncogene|November 27, 2013
Selective roles of E2Fs for ErbB2- and Myc-mediated mammary tumorigenesisL Wu, A de Bruin, H Wang, et al.
British Journal of Cancer|October 27, 2004
Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastomaD Astuti, M Morris, C Krona, et al.
Oncogene|February 2, 1995
A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTCC Eng, D P Smith, L M Mulligan, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 1998
Germline RET codon 918 mutation in apparently isolated intestinal ganglioneuromatosisC Eng, D J Marsh, B G Robinson, et al.
Nature Genetics|May 1, 1997
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndromeD Liaw, D J Marsh, J Li, et al.
The British Journal of Surgery|March 3, 2016
Impact of multimodal therapy in locally recurrent rectal cancerY N You, J M Skibber, C-Y Hu, et al.
Journal of Medical Genetics|June 14, 2000
Over-representation of PPARgamma sequence variants in sporadic cases of glioblastoma multiforme: preliminary evidence for common low penetrance modifiers for brain tumour risk in the general populationX P Zhou, W M Smith, O Gimm, et al.
Nature Genetics|September 6, 2000
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancerW M Grady, J Willis, P J Guilford, et al.
Pageof 39

Showing results (311-320 of 385) with videos related to

Sort By:
Pageof 39
Oncogene|August 26, 1998
Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancerM G FitzGerald, D J Marsh, D Wahrer, et al.
Annals of Surgical Oncology|January 14, 2015
Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial NeoplasmsJ H Choe, M J Overman, K F Fournier, et al.
Oncogene|November 27, 2013
Selective roles of E2Fs for ErbB2- and Myc-mediated mammary tumorigenesisL Wu, A de Bruin, H Wang, et al.
British Journal of Cancer|October 27, 2004
Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastomaD Astuti, M Morris, C Krona, et al.
Oncogene|February 2, 1995
A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTCC Eng, D P Smith, L M Mulligan, et al.
The Journal of Clinical Endocrinology and Metabolism|December 16, 1998
Germline RET codon 918 mutation in apparently isolated intestinal ganglioneuromatosisC Eng, D J Marsh, B G Robinson, et al.
Nature Genetics|May 1, 1997
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndromeD Liaw, D J Marsh, J Li, et al.
The British Journal of Surgery|March 3, 2016
Impact of multimodal therapy in locally recurrent rectal cancerY N You, J M Skibber, C-Y Hu, et al.
Journal of Medical Genetics|June 14, 2000
Over-representation of PPARgamma sequence variants in sporadic cases of glioblastoma multiforme: preliminary evidence for common low penetrance modifiers for brain tumour risk in the general populationX P Zhou, W M Smith, O Gimm, et al.
Nature Genetics|September 6, 2000
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancerW M Grady, J Willis, P J Guilford, et al.
Pageof 39